Clinical Trial Update: Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF) [NA]

View source ↗

Summary

NECTAR-HF is a neural stimulation therapy trial for heart failure. The study is currently not recruiting and results were posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• NECTAR-HF neural stimulation therapy

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Heart Failure, Congestive Heart Failure | NA | Status: ACTIVE_NOT_RECRUITING | Results posted: 2020-01-06